Investors are focusing on Adtalem Global Education as the for-profit education provider prepares to release its second-quarter fiscal 2026 results on January 28. The upcoming report follows a period of strong operational performance but is set against a backdrop of legal scrutiny that market participants are monitoring.
Strong Operational Momentum Sets the Stage
The company enters this earnings cycle from a position of strength, buoyed by impressive first-quarter figures. For the period ending September 2025, Adtalem reported adjusted earnings per share (EPS) of $1.75, marking a substantial 35.7% year-over-year increase. Revenue climbed 10.8% to $462.3 million. Perhaps most indicative of sustained growth is the enrollment trend: total student enrollments reached 97,359, representing the ninth consecutive quarter of enrollment growth. Walden University notably achieved a record high, with enrollments surging 13.6%.
Based on this robust start, management has reaffirmed its full-year fiscal 2026 guidance. The company continues to project revenue in the range of $1.9 billion to $1.94 billion and adjusted EPS between $7.60 and $7.90.
Shareholder Returns and Legal Overhang
Management’s confidence in the business is further evidenced by its capital allocation strategy. The board recently authorized a new share repurchase program worth $750 million, extending through December 2028. This follows the complete utilization of a previous $150 million buyback initiative, with both programs aimed at enhancing shareholder value.
Should investors sell immediately? Or is it worth buying Adtalem Global Education?
However, this financial optimism is tempered by a legal development. The company is currently under review by attorneys examining a potential securities fraud investigation. The probe appears to center on decelerating growth rates at Chamberlain University, introducing an element of uncertainty for the investment community.
Strategic Initiatives on the Horizon
Looking beyond the imminent quarterly release, Adtalem has scheduled an Investor Day for February 24, 2026. This event is expected to detail the organization’s long-term strategic vision and its framework for capital allocation.
Furthermore, the company is advancing a key initiative in partnership with Google Cloud to develop an AI certificate program tailored for healthcare professionals. The January 28 earnings report will serve as a critical indicator of whether the positive operational trends remain intact and how leadership is navigating the current challenges.
Ad
Adtalem Global Education Stock: Buy or Sell?! New Adtalem Global Education Analysis from January 16 delivers the answer:
The latest Adtalem Global Education figures speak for themselves: Urgent action needed for Adtalem Global Education investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from January 16.
Adtalem Global Education: Buy or sell? Read more here...








